Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Greater Saphenous Vein (GSV) Insufficiency Using Echo-Guided Sclerotherapy With Lauromacrogol 400 Foam -Comparative Study of 3% Versus 1% Concentration.

NCT00348764 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT00348764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00348764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Greater Saphenous Vein (GSV) Insufficiency Using Echo-Guided Sclerotherapy With Lauromacrogol 400 Foam -Comparative Study of 3% Versus 1% Concentration.
Lead sponsor
University Hospital, Grenoble
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2004
Completion date
December 31, 2006
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

saphenous vein, venous insufficiency